Medications

EU watchdog's rejection of ALS drug angers patients

The European Union drug watchdog's refusal to approve an ALS drug already authorized in North America has been called "an affront" by angry French patients, who say they "don't have time to wait".

Obstetrics & gynaecology

Promising findings for anti-alcohol treatment in pregnancy

A study by researchers from The University of Western Australia and Telethon Kids Institute has found a medication that helps people refrain from drinking alcohol has shown no harmful effects during pregnancy in early stage ...

Oncology & Cancer

EU approves treatment for prostate cancer

The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.

Vaccination

Japanese dengue vaccine becomes second approved by EU

Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.

Alzheimer's disease & dementia

Controversial Alzheimer's drug approval sparks surprising impact

When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University ...

page 3 from 20